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Microarray gene expression profiles of fasting induced changes in liver and
adipose tissues of pigs expressing the melanocortin-4 receptor D298N
variant
Abstract
Transcriptional profiling coupled with blood metabolite analyses were used to identify porcine genes and
pathways that respond to a fasting treatment or to a D298N missense mutation in the melanocortin-4 receptor
(MC4R) gene. Gilts (12 homozygous for D298 and 12 homozygous for N298) were either fed ad libitum or
fasted for 3 days. Fasting decreased body weight, backfat, and serum urea concentration and increased serum
nonesterified fatty acid. In response to fasting, 7,029 genes in fat and 1,831 genes in liver were differentially
expressed (DE). MC4R genotype did not significantly affect gene expression, body weight, backfat depth, or
any measured serum metabolite concentration. Pathway analyses of fasting-induced DE genes indicated that
lipid and steroid synthesis was downregulated in both liver and fat. Fasting increased expression of genes
involved in glucose sparing pathways, such as oxidation of amino acids and fatty acids in liver, and in
extracellular matrix pathways, such as cell adhesion and adherens junction in fat. Additionally, we identified
DE transcription factors (TF) that regulate many DE genes. This confirms the involvement of TF, such as
PPARG, SREBF1, and CEBPA, which are known to regulate the fasting response, and implicates additional
TF, such as ESR1. Interestingly, ESR1 controls several fasting induced genes in fat that are involved in cell
matrix morphogenesis. Our findings indicate a transcriptional response to fasting in two key metabolic tissues
of pigs, which was corroborated by changes in blood metabolites, and the involvement of novel putative
transcriptional regulators in the immediate adaptive response to fasting.
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Lkhagvadorj S, Qu L, Cai W, Couture OP, Barb CR, Hausman
GJ, Nettleton D, Anderson LL, Dekkers JC, Tuggle CK. Microar-
ray gene expression profiles of fasting induced changes in liver and
adipose tissues of pigs expressing the melanocortin-4 receptor D298N
variant. Physiol Genomics 38: 98–111, 2009. First published April 14,
2009; doi:10.1152/physiolgenomics.90372.2008.—Transcriptional profiling
coupled with blood metabolite analyses were used to identify porcine
genes and pathways that respond to a fasting treatment or to a D298N
missense mutation in the melanocortin-4 receptor (MC4R) gene. Gilts
(12 homozygous for D298 and 12 homozygous for N298) were either
fed ad libitum or fasted for 3 days. Fasting decreased body weight,
backfat, and serum urea concentration and increased serum nonest-
erified fatty acid. In response to fasting, 7,029 genes in fat and 1,831
genes in liver were differentially expressed (DE). MC4R genotype did
not significantly affect gene expression, body weight, backfat depth,
or any measured serum metabolite concentration. Pathway analyses of
fasting-induced DE genes indicated that lipid and steroid synthesis
was downregulated in both liver and fat. Fasting increased expression
of genes involved in glucose sparing pathways, such as oxidation of
amino acids and fatty acids in liver, and in extracellular matrix
pathways, such as cell adhesion and adherens junction in fat. Addi-
tionally, we identified DE transcription factors (TF) that regulate
many DE genes. This confirms the involvement of TF, such as
PPARG, SREBF1, and CEBPA, which are known to regulate the
fasting response, and implicates additional TF, such as ESR1. Inter-
estingly, ESR1 controls several fasting induced genes in fat that are
involved in cell matrix morphogenesis. Our findings indicate a tran-
scriptional response to fasting in two key metabolic tissues of pigs,
which was corroborated by changes in blood metabolites, and the
involvement of novel putative transcriptional regulators in the imme-
diate adaptive response to fasting.
transcription; ESR1; MC4R; feed deprivation
ENERGY HOMEOSTASIS IS AN ESSENTIAL physiological component
of all living organisms and when disrupted can lead to com-
plicated conditions such as diabetes, obesity, and anorexia. The
pig is a major source of human food worldwide and is also well
suited as a model for investigations into human homeostatic
mechanisms (54, 63). Thus, understanding the mechanisms
that regulate food intake can contribute knowledge relevant to
human health and improve agricultural economy, as feed is the
largest variable cost in pork production, ranging from 57 to
68% of the total variable cost (29, 44).
In humans and rodents, the melanocortin system plays a
pivotal role in food intake regulation. In particular, the mela-
nocortin-4 receptor (MC4R), a G protein-coupled seven-trans-
membrane receptor, integrates and relays key signals control-
ling food intake (2, 78). In pigs, central administration of the
MC4R agonist NDP-MSH suppresses feed intake (4), and a
missense variant N298 of the MC4R gene was associated with
increased feed intake, growth, and backfat (41). Studies on the
effects of N298 on MC4R function indicate that the D298
variant may be required for normal receptor signaling (42).
Interestingly, HEK-293 cells transfected with the D298 variant
stimulated cAMP production in response to NDP-MSH, but
no stimulation was observed for the N298 variant in this model
system (42). These reports indicate that the role of MC4R in
food intake control extends to the porcine species.
Recent advances have been made in swine transcriptomics
(23, 74), where transcriptional profiling was successfully em-
ployed to probe several porcine tissues such as adipose (31),
muscle (50), lung (82), and neural (59) tissues. Studies with
rodent models have reported transcriptional responses to fast-
ing in heart (70), hypothalamus (48), muscle (73), liver, and
adipose (7, 49, 55) tissues. Several groups have investigated
the roles of specific metabolic genes during fasting (5, 28, 67),
but global transcriptional profiling of the fasting response has
not been reported in the porcine species. Fasting studies in
rodent species have also not included global analysis of key
regulatory transcription factors (TF) that may be responsible
for the differentially expressed (DE) genes. Several TF and
nuclear receptors are known to mediate the fasting response
(13, 18, 46), and their function appears to regulate specific
metabolic adjustments within each peripheral organ and to
coordinate intertissue communication for homeostasis. Previ-
ous studies have established regulatory roles for several TF in
fat and/or liver tissues in rodents and pigs, such as sterol
regulatory element binding factor 1 and 2 (SREBF1 and
SREBF2) (40), CCAAT/enhancer binding protein alpha (C/
EBP) (53), peroxisome proliferator-activated receptors beta
(77), gamma (PPAR) (76), and alpha (PPAR) (13, 39).
We hypothesize that transcriptional profiling of over 24,000
genes in key metabolic tissues of pigs, corroborated by blood
metabolite analyses, will identify pathways and transcriptional
networks of genes responding to fasting or MCR4 genotype.
The results may implicate candidate genes to improve feed
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efficiency in pigs. We report 7,029 genes in adipose tissue and
1,831 genes in liver to be DE (q 0.05) due to a 3-day fast. We
also report on ensuing key biological processes. Major regu-
lators of responding genes to fasting were identified by assess-
ing the connection of DE TF to the DE genes. This study
reports 1) the first global study on feed deprivation using
transcription profiling of key tissues in pig, 2) identification of
key TF in global fasting response, and 3) analysis of shared
biological pathways in the fasting response between fat and
liver.
MATERIALS AND METHODS
Animals and Feed Treatments
Six-month-old Yorkshire gilts from a line selected for high feed
efficiency, based on low residual feed intake (9) were used. Animals
were fed ad libitum a crude protein standard swine diet with 20%
crude protein until weaning (Kent Feeds, Muscatine, IA) and with
16–17.5% crude protein diet after weaning (Mid-State Milling, State
Center, IA). Pigs were genotyped for the MC4R variant D298N (41),
and 12 animals homozygous for N298 and 12 animals homozygous
for D298 were randomly assigned to treatments. Starting at 06:00 on
day 1, gilts were fed ad libitum with continuous access to feed until
08:00 on day 4 or had feed removed for 3 days in a randomized
complete block design with a 2  2 factorial arrangement of treat-
ments. A total of six animals were used for each combination of
genotype and feed treatment across the four blocks that were defined
as animals that underwent treatment on the same day. Each block
contained at least one animal from each combination of genotype and
feed treatment. All animals received water ad libitum. On day 4
(09:00–11:30), pigs were killed by electric stunning, and samples of
hepatic tissue and the 10th rib middle layer of backfat were rapidly
collected, frozen in liquid nitrogen, and stored at 80°C until RNA
isolation. Pretreatment blood samples were collected the day before
start of the feeding treatment from the jugular vein. Terminal blood
samples were collected during postmortem exsanguinations. Blood
samples were allowed to clot at 4°C overnight and centrifuged at
1,200 g for 30 min, and serum was collected and stored at 20°C. The
protocol for animal experiments was reviewed and approved by the
Institutional Animal Care and Use Committee of Iowa State Univer-
sity (protocol #12-04-5797-S).
Body Weight, Backfat, Liver Glycogen, and Blood Parameters
Pre- and posttreatment body weight and 10th rib backfat depth
were measured on days 0 and 4 (16:00–18:00). Backfat depth was
measured by ultrasound (9) using an Aloka 500 V SSD ultrasound
instrument fitted with a 3.5-MHz, 12.5-cm, linear-array transducer
(Corometrics Medical Systems, Wallingford, CT). Liver glycogen
was determined as reported previously (25). Briefly, samples of liver
tissue (0.45 g) were extracted in cold perchloric acid (0.5 mol/l) using
a Tissue Tearor homogenizer. Duplicate samples (300 l) of each
homogenate were then prepared for glycogen hydrolysis with 0.3 g/l
amyloglucosidase (Sigma-Aldrich, St. Louis, MO) for 120 min at
38°C. The incubation was stopped by the addition of 0.6 mol/l
perchloric acid and the samples clarified by centrifugation (1,500 g,
15 min at 4°C). Glucose (HK) assay kits (Sigma-Aldrich) were used
to determine total micromolar glycosyl units (glucose, glucose-6-P,
and glucose from glycogen) from the clarified samples and from the
original homogenate (glucose, glucose-6-P only). Results were ex-
pressed as mg glycosyl per g wet tissue. Posttreatment serum samples
were assayed for concentrations of glucose (hexokinase assay, Roche
Diagnostics, Indianapolis, IN), urea (UREA/BUN kit by Roche Di-
agnostics), and triglyceride (TG, cat. #236-99; Diagnostics Chemi-
cals, Oxford, CT). Nonesterified fatty acids (NEFA) concentration
was measured on both pre- and posttreatment samples [HR Series-
NEFA HR (2); Wako Diagnostics, Richmond, VA].
RNA Isolation and Microarray Hybridization
Total RNA was isolated and purified from liver and adipose tissues
using the Qiagen RNeasy midi kit and the Qiagen RNeasy lipid tissue
kit (Qiagen, Valencia, CA). Quality and quantity of RNA were
determined by electrophoresis and spectrophotometry with the Agi-
lent 2100 Bioanalyzer (Foster City, CA). Average RNA integrity
numbers were 9.0  0.5 for liver RNA and 8.2  0.5 for fat RNA
samples. Microarray target sample processing, target hybridization,
washing, staining, and scanning steps were completed according to
manufacturer’s instructions (Affymetrix, Santa Clara, CA). Briefly, 10
g of total RNA from liver and adipose tissues was used to synthesize
cDNA using a one-cycle cDNA synthesis kit. Resulting cDNA from
each sample was used to transcribe biotinylated cRNA by T7 RNA
polymerase and further fragmented and applied to the Affymetrix
GeneChip Porcine Genome Array that contains 24,123 probe sets.
Following hybridization at 45°C for 16 h, the array was washed and
stained with streptavidin-phycoerythrin at an Affymetrix GeneChip
Fluidics Station 450, and fluorescent signals were scanned using an
Affymetrix GeneChip Scanner 3000 (3). Each tissue was assigned to
one Fluidics station to remove potential station effects for within-
tissue comparisons, and four modules within each station were inten-
tionally confounded with the blocks.
Transcriptome
The Affymetrix GeneChip Porcine Genome Array probe set con-
tains 11 paired perfect match (PM) and mismatch (MM) 25-mer
probes (3). The probe-pair (PM-MM) data were used to determine the
detection call (present call, marginal call, and absent call) by the
modified Wilcoxon signed rank test of the MAS 5.0 software (50). For
each tissue, probe sets with absent calls for all replicates in all
treatments were removed, and the remaining probe sets were declared
as expressed and established the transcriptome for that tissue.
Statistical Analyses
Animal performance, blood parameters, and liver glycogen. Body
weight, average daily feed intake, backfat change, liver glycogen
content, and blood parameters were analyzed by a mixed linear model
with genotype, feed treatment, and their interactions as fixed effects
and block as a random effect using the Mixed procedure of SAS/
STAT software version 9.1.3 (SAS Institute, Cary, NC). The values
for NEFA were natural log transformed to improve normality and
homoscedasticity. Residual diagnostics identified no obvious con-
cerns about the models used in all tests.
Gene expression. Affymetrix GeneChip Operating Software
(GCOS) version 1.4.0 was used to obtain .CEL files at the GeneChip
Facility at Iowa State University. Data were deposited in the National
Center for Biotechnology Information (NCBI) Gene Expression Om-
nibus (series accession #GSE13528; http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?accGSE13528) and examined at the probe level
with BioC version 2.0 (27) in R (60). All 24,123 probes, including
absent calls, were analyzed. Three of 48 chips showed minor imaging
artifacts. Probe-level measures were summarized into probe set level
expression measures according to the MAS 5.0 algorithm (3) using the
“affy” package (36) in R, except that the final step of aligning the
trimmed means on the log scale was omitted because it was redundant
with the median centering that was implemented in later steps. By
replacing the PM and MM values with the corresponding probe set
level measures, we constructed pseudoarray images, and visual data
quality check indicated that previous imaging artifacts were success-
fully corrected at the probe set level. Base 2 logarithms were taken,
and the median expression measures from each chip were examined
for treatment effects by fitting an analysis of variance model with
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genotype, feed treatment, their interaction, and block as fixed effects.
Median centering normalization (81) was performed by subtracting
the median expression from all expression measures on each chip on
the logarithmic scale.
To determine the proper model for analysis of the expression data,
81 alternative mixed linear models were fitted to the normalized
expression measures for each tissue and each gene separately using
the mixed procedure in SAS/STAT software version 9.1.3 (SAS
Institute). Models included MC4R genotype, feed treatment, and their
interaction as fixed effects but differed from each other by including
any subset of block (four levels), chip hybridization day (three levels),
the process batch during washing of the chips (three levels), and
Fluidics station final stage as recorded in the .XML files from GCOS
(two levels), as either fixed or random effects. Variance components
were estimated by the method of maximum likelihood, with nonnega-
tivity boundary constraints. The model with block and hybridization
day as random effects was selected based on gene-averaged SAS-
reported information criteria, the gene-averaged standardized predic-
tion sums of squares from leave-one-out cross-validation, specifics of
the experimental design, and histograms of P values of contrasts of
interest.
For the final model, variance components were reestimated with the
method of residual maximum likelihood with nonnegativity boundary
constraints. Fixed effect estimates and least squares means were
obtained using generalized least squares, and fixed effects contrasts
were tested using Wald-type F-tests with Kenward-Roger’s correction
(38). The positive false discovery control procedure (68) was used on
each set of P values of contrasts of interest to compute q values. Genes
with q values 0.05 were considered to be DE.
Affymetrix Probe Annotation
To obtain homologs and improved annotation, Affymetrix probe
consensus sequences were used to BLAST against the well-curated
NCBI’s RefSeq database. Highest scores were used with a conserva-
tive cutoff of 1e-10 for the E-value. In total, 17,798 (73.8% of all)
probes on the Affymetrix GeneChip Porcine Genome Array were
assigned RefSeq annotation (Couture O, Callenberg K, Kaul N, Pandit
S, Younes R, Hu Z, Dekkers J, Reecy J, Honavar V, Tuggle C,
unpublished observations).
Pathway Analysis With Gene Ontology and KEGG
DE (q  0.05) genes in fat and liver were divided into genes that
were down- or upregulated in fat or liver as a result of fasting, creating
four categories of genes. Using DAVID, an open access web-based
functional annotation and clustering program (17), the four categories
of genes were analyzed for overrepresented (P  0.05) biological
process categories based on Gene Ontology’s (GO) Biological Pro-
cess and Kyoto Encyclopedia Genes and Genomes (KEGG) data-
bases. The P values for overrepresentation were computed by a
modified Fisher’s exact test, using the transcriptome for each tissue as
background. The biological process categories were clustered using
Functional Annotation Clustering (17), where the enrichment score
for each cluster was computed as the negative log of the geometric
mean of P values in the cluster. Additionally, the top 50 DE genes
(q  0.05) based on fold change in each of the four categories were
functionally annotated to determine pathways that were populated by
genes with high fold changes.
Pathway Studio Analyses
DE genes (q  0.05) in fat or liver tissues were analyzed with
Pathway Studio 5.0 (57), a text mining tool that detects relationships
among genes, proteins, cell processes, and diseases as recorded in the
PubMed database (Ariadne Genomics, Rockville, MD). The previously
defined four categories of DE genes were assessed for reported (PubMed)
associations with common regulatory TF and nuclear receptors based on
regulation, direct regulation, binding, and/or promoter binding. Genes
satisfying these criteria were counted for each regulatory TF. Because of
the limited processing capacity of Pathway Studio, only DE genes with a
fold change 2 were used in this analysis.
Real-time Quantitative PCR for Verification of DE Genes
Real-time quantitative PCR (qPCR) was used to verify fasting-
induced differential expression of seven genes in adipose tissue and
eight genes in liver. Total RNA was isolated from backfat of pigs that
were arrayed by Affymetrix GeneChip Porcine Genome Array as
described above and reverse transcribed to cDNA using Superscript II
reverse transcriptase (Invitrogen, Carlsbad, CA) and oligo(dT) (16).
Real-time PCR was performed in duplicate using 100 ng cDNA (RNA
equivalent) per 25 l reaction or per well with the Brilliant kit
(Stratagene, La Jolla, CA) on Bio-Rad MyiQ Single Color Real Time
PCR Detection System (Bio-Rad). All probes and primers for real-
time TaqMan PCR were designed (Supplementary Table 11) using
Primer Express 2.0 (Applied Biosystems, Foster City, CA), as previ-
ously described (16). The probes contained 3	Iowa Black FQ
quencher and 5	 6-FAM reporter (Integrated DNA Technologies,
Coralville, IA). The PCR conditions were 50°C for 2 min, 95°C for 10
min, 40 cycles of 95°C for 15 s and 60°C for 1 min, then 4°C. Because
variation in the expression of commonly used housekeeping genes
such as GAPDH, HMBS, HPRT, SDHA, RPL32, YWHAZ, and UBC
(75) was observed with a 3-day fasting treatment in one or both
tissues, we normalized gene expression based upon the constant
amount of RNA and cDNA amplified. This method has been proposed
as the most reliable standardization of quantitative measurement of
mRNA expression given that accurate estimation of total RNA is
made with tools such as Agilent Bioanalyzer (8).
Quantification of gene expression was analyzed as previously
reported (16). Briefly, cycle threshold (Ct) values averaged across
duplicate readings were analyzed by a mixed linear model with
genotype, feed treatment, and their interactions as fixed effects, and
block as a random effect, using the Mixed procedure of SAS/STAT
software version 9.1.3 (SAS Institute). A value of P  0.05 was
considered statistically significant. Fold change in expression was
calculated as 2
Ct for each gene, where 
Ct is the difference between
least square mean Ct values for the fasting and ad libitum groups.
RESULTS
Fasting and MC4R Genotype Effects on Body Weight,
Backfat, Liver Glycogen, and Serum Metabolites
The effects of a 3-day fast and MC4R genotype on body
weight, backfat change, liver glycogen content, and serum
metabolites are in Table 1. Fasted animals lost 5.5 kg or 6.7%
of their body weight, whereas those fed ad libitum gained 2.5
kg or 3.2%. No evidence of a significant effect of MC4R
genotype on body weight (P  0.75) was noted. Pigs homozy-
gous for N298 were previously reported (41) to have higher
average daily feed intake (P  0.05) than pigs homozygous for
D298; however, we observed an opposite trend (P  0.09) in
our study.
Pretreatment backfat depth was not significantly different
(P  0.17) between feeding treatments but was significantly
higher (P  0.05) for pigs homozygous for N298 than for pigs
homozygous for D298, which agrees with a previous report (41).
Therefore, within-individual change in backfat depth due to fast-
ing treatment was analyzed rather than posttreatment backfat
depth to account for the initial backfat difference due to MC4R
1 The online version of this article contains supplemental material.
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genotype (Table 1). Fasted pigs had on average greater backfat
loss than the fed group (ad libitum  0.77 mm, fasted  0.49
mm, P  0.022), indicating that body lipid stores were mobilized
as an energy source during feed deprivation.
Fasted pigs had 67% less glycogen content compared with
the fed group (ad libitum  13.8 ng/mg, fasted  4.6 ng/mg)
(Table 1). Pretreatment NEFA concentration did not differ
between the fasted and fed groups (P  0.16); however,
posttreatment serum NEFA concentrations were 127% greater
(P  0.0002) in fasted than ad libitum-fed animals. Posttreat-
ment serum concentration of blood urea nitrogen was 24%
lower in fasted pigs (P  0.006), but neither fasting nor MC4R
genotype had a significant effect on posttreatment blood glu-
cose or TG concentrations.
Fasting and MC4R Effects on Expression of Genes in Fat
and Liver
Of 24,123 probe sets evaluated by microarray analysis,
19,885 and 19,162 provided data indicating the transcripts
represented by these probe sets were expressed in fat and liver
tissue, respectively. In response to a 3-day fasting treatment,
7,937 transcripts were identified to be DE (q  0.05, P 
0.029) in fat, with 3,722 being upregulated and 4,215 down-
regulated. In liver, 1,832 transcripts were identified to be DE
(q  0.05, P  0.006), of which 1,287 were upregulated and
545 downregulated (Supplementary Tables 2A and 2B). An
improved annotation of probe sets on the Affymetrix GeneChip
Porcine Genome Array (Couture O, Callenberg K, Kaul N,
Pandit S, Younes R, Hu Z, Dekkers J, Reecy J, Honavar V,
Tuggle C, unpublished observations) assigned gene names
(BLASTN expectation score 1e-10) to 90 and 83% of DE
transcripts (q  0.05) due to fasting in liver and in fat,
respectively. For simplicity, the changes in RNA levels de-
tected by these annotated probe sets are referred to as gene
expression differences for the rest of the paper. The gene-by-
gene analysis that was conducted did not identify evidence of
effects of MC4R genotype or of the interaction between geno-
type and feeding treatment at q  0.05; thus, only the effects
of fasting on gene expression were considered in further
analyses.
Microarray Data Validation by qPCR
Expression patterns of seven genes representing the lipid
biosynthetic pathways in subcutaneous adipose tissue and of
eight genes in liver representing the gluconeogenesis, fatty acid
oxidation, ketogenesis, or steroid synthesis pathways were
verified by qPCR in fasted vs. ad libitum treatments (Fig. 1,
Supplementary Table 3). For all tested genes, expression fold
changes (ad libitum vs. fasted) were consistent in direction
with the microarray results (Fig. 1). Statistical significance of
fold changes (ad libitum vs. fasted) was also confirmed by
qPCR (P  0.05) for all genes except for insulin-like growth
factor 1 (IGF1, P  0.13) and IGF1 receptor (IGF1R, P 
0.94) in fat and for hydroxyacyl-coenzyme A dehydrogenase
(HADHA, P  0.09) in liver. IGF1 and IGF1R had low fold
changes in microarray analysis (1.35 and 1.84, respectively)
and low expression levels in adipose tissue compared with the
other four genes, whose absolute expression fold changes
ranged from 2.5 to 27.4 in microarray analysis. Overall, the
results obtained from microarray were statistically confirmed
for 80% of the tested genes in liver and fat.
Biological Processes Affected by Fasting in Fat and Liver
To identify biological processes that respond to fasting, lists
of DE genes in liver and fat were explored for overrepresen-
tation of GO Biological Process categories, and the resulting
overrepresented terms were clustered (Supplementary Table 4,
A–D). In addition, the KEGG biological pathway database was
used to identify specific biological pathways that were over-
represented by genes that responded to fasting (P  0.05). A
summary of KEGG annotations are shown in Fig. 2 and
described further in the following sections.
Fasting Effects in Fat
Subcutaneous adipose tissue underwent significant gene ex-
pression changes that were reflected by the large number of DE
genes (7,937), compared with liver (3,722). Indicative of a
metabolic switch toward energy conservation in response to
fasting, genes involved in direct energy-generating processes,
such as oxidative phosphorylation, ATP synthesis, and TCA
Table 1. Body weights, backfat changes, and serum parameters in pigs fed at ad libitum and fasted and that
are homozygous for MC4R variant D298 or variant N298
Trait
Fed at Ad Libitum Fasted
SE Feeding P ValueD298 N298 D298 N298
Feed intake, kg/day* 2.4a 2.2a 0 0 0.2
Initial body weight, kg 81.0a 80.4a 82.0a 81.6a 1.8 0.4634
Final body weight, kg 83.5a 83.0a 76.5b 76.0b 2.2 0.0002
Initial backfat, mm 11.0a 13.2b 12.8a,b 13.2b 0.7 0.1738
Backfat post-pre change, mm 0.89a 0.64a 0.30a 1.27b 0.5 0.0219
Glycogen in liver (ng/mg of liver) 14.2a 13.6a 4.2b 4.9b 2.0 0.0001
Glucose, mg/dl 89.4a 78.0a 92.0a 90.7a 6.9 0.2444
Triglyceride, mg/dl 33.8a 29.0a 39.2a 40.2a 4.3 0.0708
Pretreatment NEFA ln(mEq/ml)† 4.7a 4.7a 4.9a 5.22a 0.2 0.1589
Posttreatment NEFA, ln(mEq/ml) 5.2a 5.4a 6.2b 6.0b 0.2 0.0001
Urea, mg/dl 16.7a,b 17.1a 13.2b,c 12.5c 1.8 0.0056
Values are least square means and SE pooled across treatments, n  6 per genotype by feeding treatment combination. The P values correspond to the main
effect of feeding treatment. The effects of MC4R genotype and feed by genotype interaction were nonsignificant for all traits (P  0.09) except for initial backfat
depth (P  0.05). Least square means within the same line that do not share the same superscript letter are significantly different at P  0.05. *Feed intake was
averaged over the 3-day treatment period and only pigs fed ad libitum were used to test the genotype effect. †Nonesterified fatty acid (NEFA) concentration data
were natural log transformed.
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cycle, were downregulated in fasted pigs. Likewise, genes
involved in energy-intensive biosynthetic and catabolic pro-
cesses were downregulated in the fasted pigs (Fig. 2, Supple-
mentary Table 4A). This included genes encoding biosynthetic
pathways, such as steroid and lipid biosynthesis, fatty acid
synthesis, protein translation, amino acid synthesis, and ubiqui-
none biosynthesis, as well as genes encoding enzymes in-
volved in catabolic processes, such as glucose metabolism,
proteolysis, amino acid degradation, and pyruvate metabolism.
Fasting induced upregulation of adipose genes involved in
cytoskeleton reorganization, such as actin polymerization and
cell-to-cell adhesion machinery, as well as genes involved in
signal transduction pathways, such as adipocytokine signaling
(Fig. 2, Supplementary Table 4B).
Fasting Effects in Liver
Liver is a primary site of glucose generation and sparing
processes during fasting, such as gluconeogenesis and keto-
genesis. Fasting induced upregulation of genes in gluconeo-
genesis as well as genes involved in energy derivation pro-
cesses, such as fatty acid metabolism, glycolysis, pyruvate
metabolism, proteasome, and amino acid degradation (Fig. 2,
Supplementary Table 4C). Similar to what was observed for
fat, liver downregulated expression of genes involved in lipid
and steroid biosynthetic processes in response to fasting (Fig.
2, Supplementary Table 4D).
Genes and Pathways That Responded to Fasting in Both Fat
and Liver
Genes found to be DE in both liver and adipose tissues
(Fig. 3A) and KEGG pathways overrepresented (P  0.05)
in these genes were identified (Fig. 3B). In response to
fasting, both liver and adipose tissues downregulated synthesis
of steroids. When the top 50 significantly (q  0.05) down-
regulated genes based on highest fold change in fat and in liver
were analyzed, the steroid biosynthesis pathway was also the
most significantly populated in both tissues (P  8.7e-05 in fat,
P  2.8e-10 in liver) (Fig. 4). Within these top 50 downregu-
lated liver genes were seven genes that encode enzymes in-
volved in biosynthesis of steroids. These had fold changes
ranging from 2.6 to 7.6 (3-hydroxy-3-methylglutaryl-coen-
zyme A reductase, 7-dehydrocholesterol reductase, sterol
isomerase, isopentenyl-diphosphate  isomerase 1, mevalonate
decarboxylase, squalene epoxidase, and sterol-C5-desaturase-
like). Similarly, the top 50 downregulated genes in fat con-
tained four genes involved in steroid biosynthesis (mevalonate
kinase, sterol isomerase, isopentenyl-diphosphate delta isomer-
ase 1, and mevalonate decarboxylase), with fold changes rang-
ing from 4.0 to 6.5.
Of 13 genes annotated by KEGG to encode enzymes in the
steroid synthesis pathway, 12 are represented by probe sets on
the Affymetrix GeneChip Porcine Genome Array. Ten of these
genes, including the rate limiting enzyme 3-hydroxy-3-meth-
ylglutaryl-coenzyme reductase, were significantly downregu-
lated (q  0.05) in response to fasting in both fat and liver
tissues. Exceptions were farnesyl diphosphate farnesyltrans-
ferase 1, which was significantly downregulated in liver but not
in fat, and geranylgeranyl diphosphate synthase, which was
downregulated in fat but not in liver (Table 3).
Pathways With an Opposite Fasting Response in Liver
and Fat
Fasting induced five KEGG biological pathways in a distinct
tissue-dependent manner, in which they were significantly
downregulated (P  0.05) in fat but upregulated in liver (Fig.
Fig. 1. Microarray data validation on a subset of differentially expressed genes
(q  0.05) by qPCR in liver and fat. A: representative genes in the lipid
biosynthesis pathway in adipose tissue. B: representative genes in the glucone-
ogenesis, fatty acid oxidation, ketogenesis, or steroid synthesis pathways in
liver. Official gene symbols were used as abbreviations. ACACA, acetyl-
coenzyme A carboxylase alpha; ACSL-1, acyl-CoA synthetase long-chain
family member 1; FASN, fatty acid synthase; ACO1, aconitase 1; SREBF1,
sterol regulatory element binding factor 1; IGF1, insulin-like growth factor 1;
HADHA, hydroxyacyl-Coenzyme A dehydrogenase; PC, pyruvate carboxy-
lase; ACADL, acyl-Coenzyme A dehydrogenase, long chain; DHCR7, 7-de-
hydrocholesterol reductase; SQLE, squalene epoxidase; HMGCR, 3-hydroxy-
3-methylglutaryl-Coenzyme A reductase; ECH1, enoyl Coenzyme A hydratase
1; HMGCS1, 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1. MA, mi-
croarray. Fold changes are expressed as (fasted/ad libitum), in which negative
fold changes indicate downregulation while positive fold changes indicate
upregulation of expression due to fasting.
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3B). Two of these five pathways were glucose sparing
(branched chain amino acids and propanoate metabolism) and
were overrepresented among the 50 upregulated liver genes
with the highest fold changes (Fig. 4). Genes in the propanoate
metabolism and pyruvate metabolism pathways, which lead to
succinyl CoA and acetyl CoA, respectively, were upregulated
in liver and downregulated in fat. These provide starting and
intermediate materials for the TCA cycle, indicating that fast-
ing affected the TCA cycle in fat and liver in different fashions.
Energy derived via the TCA cycle in liver likely was used for
gluconeogenesis, which is energetically costly.
Key Transcriptional Regulators of Fasting Response
Most of the changes in RNA levels are likely due to changes
in levels of transcription. To understand the main transcrip-
tional regulation involved in the fasting response, genes that
were up- and downregulated in liver and fat (q  0.05) were
analyzed for their connections to common TF or nuclear
receptor regulators by using Pathway Studio 5.0. Connections
between DE (q  0.05) TF and their targets within the four DE
gene lists were populated based on literature evidence of at
least one of four interaction categories provided by Pathway
Studio 5.0, which were promoter binding, binding, regulation,
and direct regulation. Common regulators with the highest
number of target genes across all four categories were deter-
mined (Fig. 5) and their target genes were functionally anno-
tated (KEGG overrepresentation P  0.05).
The most connected TF for downregulated genes in fat due
to fasting was E2F transcription factor 1 (E2F1), which is
known to regulate cell cycle and DNA replication. As ex-
pected, downregulated fat genes involved in cell cycle pro-
cesses were overrepresented among the E2F1 targets (Fig. 5).
In addition, several of the 10 most connected TF of downregu-
lated fat genes are known to modulate homeostatic responses,
Fig. 2. Functional annotation of liver and adi-
pose tissue-specific fasting response by identify-
ing overrepresented KEGG biological pathways
(P  0.05) in differentially expressed genes.
Biological processes were subdivided according
to KEGG pathway maps.
Fig. 3. Genes and pathways responding to fasting in liver and fat with either the same or opposite pattern in response to fasting. A: Venn diagram of overlapping
up- and downregulated genes (q  0.05) between liver and adipose tissue. B: shared up- and downregulated pathways and their functions (KEGG P  0.05)
in response to fasting across adipose and liver tissues.
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including PPAR (regulator of adipose differentiation and
glucose metabolism), C/EBP (adipogenesis, leptin expres-
sion), and SREBF1 (lipid and steroid synthesis). The most
connected TF of downregulated liver genes due to fasting was
tumor protein p53, whose target gene annotations were primar-
ily in the cell cycle pathway, indicating decreased cell prolif-
eration in response to fasting. Also, several of the 10 most
prominent transcriptional regulators of downregulated liver
genes are TF known to be involved in the fasting response; i.e.,
peroxisome proliferator activated receptor gamma coactiva-
tor-1 and SREBF2 (58, 65).
Among the four categories shown in Fig. 5, estrogen recep-
tor 1 (ESR1) had the most target genes of all other identified
common regulators of DE genes. Pathway analysis showed that
adherens junction and focal adhesion pathways were overrep-
resented in the upregulated adipose target genes of ESR1,
indicating that fasting induced ESR1-mediated adipocyte re-
modeling of the cytoskeleton and interaction with the extracel-
lular matrix. Forkhead box O1A was also among the top 10
common regulators of upregulated genes in fat, and has been
associated with metabolic adaptive response and in negative
feedback signaling of insulin (62). The most connected TF of
the upregulated genes in liver due to fasting was nuclear
receptor co-repressor 1 (NCOR1), which is involved in repres-
sion of transcription by nuclear receptors (37). The target genes
of NCOR1, however, did not result in significant overrepre-
sentation of any KEGG category.
DISCUSSION
This is the first study to employ transcriptional profiling
to investigate the global effects of fasting or MC4R geno-
type in the pig. Some reports are available on transcriptional
profiling of fasting response using rodent models (49, 55),
but the pig model more closely resembles human homeo-
static mechanisms than rodents (54, 63). Our main findings
demonstrate transcriptional responses across liver and adi-
pose tissue with congruent changes in serum metabolites.
Although changes in RNA expression do not always corre-
spond to changes in protein expression or activity, we
suggest that systemic changes in the expression of genes
that belong to overrepresented GO or KEGG categories
imply functional change.
Congruent to studies using rats (49, 55) we observed that, in
response to fasting, fat and liver tissues downregulated energy-
costly biosynthetic processes and upregulated genes involved
in efficient energy utilization and conservation pathways, such
as gluconeogenesis and -oxidation of fatty acids in liver (41).
Fig. 4. Fold change distribution of differentially expressed
genes due to fasting in fat and in liver. The functional
annotation of the 50 most up- and downregulated genes based
on fold change in fat and in liver (KEGG P  0.05) shows that
the biosynthesis of steroids pathway was most significantly
overrepresented by the 50 most downregulated genes in both
tissues. The highest, lowest, and the average fold changes
were 5.7, 2.3, and 2.8 for the 50 most upregulated genes in fat;
3.96, 27.4, 6.61 for the 50 most downregulated genes in
fat; 12.7, 2.02, and 3.3 for the 50 most upregulated genes in
liver; 2.6, 22.7, 4.8 for the most 50 downregulated
genes in liver.
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Fasting increased release of free fatty acid into circulation and
decreased protein degradation, as indicated by decreased serum
urea concentrations, consistent with findings in a separate
study with a 3-day fast of pigs (67).
Contrary to a previous report (41), average ad libitum
feed intake of pigs homozygous for allele D298 tended to be
greater (P  0.09) than intake of pigs homozygous for
N298, although our results are based on a very small number
and should, therefore, be interpreted with caution. In a
preliminary study, feed intake of pigs from the same popu-
lation as used in this study (9) did not change in response to
intracerebroventricular injection of NDP-MSH, a potent
activator of MC4R (C. R. Barb, unpublished data). In
addition, a recent study demonstrated that cAMP accumu-
lation did not differ between cells transfected with D298 and
N298 variants (21), in contrast to the previous report on
functional significance of D298N mutation (42). These re-
sults suggest that lack of evidence for MC4R effect on gene
expression, body weight, backfat depth, and blood parame-
ters in our study occurred perhaps due to lack of functional
significance of D298N variant or the small sample size that
was used in this study.
Fasting Induced Upregulation of Genes in Cell Adhesion
and Angiogenesis Pathways in Fat
A novel finding in our study is that fasting induced upregu-
lated expression of fat genes involved in the morphology and
structure of adipocytes, as indicated by three main biological
process clusters of cytoskeletal organization, vasculature de-
velopment, and branching structure development being over-
represented among these genes (Supplementary Table 4B).
Furthermore, three KEGG terms corresponding to adherens
junction, cell adhesion molecules, and Notch signaling (Fig. 2)
were also overrepresented among upregulated genes in fat. The
fold changes, q, and P values of genes involved in fasting-
induced angiogenesis and morphological changes are summa-
rized in Table 2. No previous report has indicated that changes
in cell-to-cell or cell-to-matrix pathways are associated with
fasting. Interestingly, a recent whole genome SNP analysis in
cattle has implicated similar pathways, such as cell adhesion
and extracellular matrix, in controlling efficiency of feed uti-
lization (6).
Metabolic response to feed deprivation has been divided into
three phases according to changes in protein and lipid utiliza-
Fig. 5. Ten highest connected transcription factors (TF) for
fasting response in the up- and downregulated genes in fat
and liver and the pathways overrepresented (KEGG P 
0.05) by the target genes of the most connected TF in each
list. Official gene symbols for the TF and nuclear receptors
were used as abbreviations. CBFB, putative C module-
binding factor; CBX5, chromobox homolog 5; CEBPA,
CCAAT/enhancer binding protein alpha; CEBPD, CCAAT/
enhancer binding protein delta; DNMT3, DNA (cytosine-
5)-methyltransferase 3 beta; E2F1, E2F transcription factor
1; ESR1, estrogen receptor 1; FOS, FBJ murine osteosar-
coma oncogene; FOXM1, forkhead box M1; GTF2B, gen-
eral transcription factor IIB; HDAC2, histone deacetylase 2;
HIF1A, hypoxia inducible factor 1, alpha subunit; HMGY,
high mobility group AT-hook 1; HSF1, heat shock factor 1;
MADH2, MAD homolog 2; MCM2, cell division control
protein 21; MITF, microphthalmia-associated transcription
factor; NCOA1, nuclear receptor coactivator 1; NCOR1,
nuclear receptor co-repressor 1; NFE2L2, nuclear factor
(erythroid-derived 2)-like 2; NR1H3, nuclear receptor sub-
family 1, group H, member 3; NR1H4, nuclear receptor
subfamily 1, group H, member 4; PER1, period homolog 1;
PER2, period 2; PPARG, peroxisome proliferator-activated
receptor gamma; PGC1, peroxisome proliferator activated
receptor gamma coactivator-1; RUNX1, runt-related tran-
scription factor 1; SPI1, spleen focus forming virus proviral
integration oncogene; SREBF1, sterol regulatory element
binding factor 1; SREBF2, sterol regulatory element binding
factor 1; TP53, tumor protein p53.
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tion (15). Our study falls into phase I, which involves a period
of adaptation resulting in glycogen breakdown and lipid mo-
bilization, as indicated by our finding of increased NEFA
release into the bloodstream and loss of 67% of liver glycogen
content (Table 1). As free fatty acids are a major source of
energy during fasting, capillaries embedded in subcutaneous
adipose tissue likely require larger surface to ensure efficient
transportation of free fatty acids. Angiogenic growth factors
are released from tissues upon need for new blood vessel
formation from preexisting vessels. In accordance with this, the
expression of critical angiogenic genes, such as those encoding
angiogenin (ANG), angiogenic factor with G patch and FHA
domains 1 (AGGF1), and vascular endothelial growth factor
(VEGF), were significantly upregulated in fat by fasting in our
study. Several cytokines and growth factors have been inves-
tigated for their involvement in angiogenesis. The inflamma-
tory cytokine, interleukin 8 (IL-8), has been shown to contrib-
ute to human melanoma progression by functioning as a
mitogenic and angiogenic factor (61), and neutralizing anti-
bodies of IL-8 inhibit angiogenesis and tumor growth (35).
Fasting upregulated IL-8 expression 2.5-fold in the adipose
tissue in the present study. Lee et al. (47) have investigated the
angiogenic properties of IGF-II in an in vitro model and
demonstrated that it directly induced angiogenesis by stimu-
Table 2. Statistical values of genes involved in the fasting induced morphological changes in the fat
Pathways Gene Description GenBank Symbol Affymetrix ID *Fold Change q Value P Value
Angiogenesis interleukin 8 IL8 Ssc.658 2.53 3.05E-02 1.54E-02
insulin-like growth factor 2 IGF2 Ssc.9365 1.16 2.15E-02 9.75E-03
natriuretic peptide receptor A/Guanylate cyclase A NPR1 Ssc.24926 1.30 1.21E-03 2.55E-04
angiogenin ANG Ssc.4679 1.93 7.08E-06 2.97E-07
endothelial PAS domain protein 1 EPAS1 Ssc.8965 1.39 1.19E-02 4.62E-03
vascular endothelial growth factor C VEGFC Ssc.12790 1.42 3.66E-02 1.95E-02
laminin, alpha 5 LAMA5 Ssc.15173 1.46 3.39E-04 5.02E-05
forkhead box C2 FOXC2 Ssc.19569 1.72 2.51E-02 1.19E-02
angiogenic factor with G patch and FHA domains 1 AGGF1 Ssc.26953 1.14 4.05E-03 1.19E-03
NMDA receptor regulated 1 NARG1 Ssc.12421 1.45 1.54E-03 3.44E-04
angiopoietin-like 4 ANGPTL4 Ssc.8980 2.36 6.41E-04 1.14E-04
B-cell translocation gene 1, antiproliferative BTG1 Ssc.6833 1.19 3.94E-04 6.08E-05
integrin, beta 3 ITGB3 Ssc.7556 1.26 1.79E-06 2.57E-05
hairy and enhancer of split-related protein 2 HEY2 Ssc.24610 1.21 0.076992 0.05356
Adherens junction mothers against DPP SMAD2 Ssc.24402 1.28 3.82E-03 1.10E-03
catenin (cadherin-associated protein) CTNNB1 Ssc.14003 1.12 1.23E-03 2.60E-04
protein tyrosine phosphatase, receptor type, F PTPRF Ssc.2337 1.26 8.98E-03 3.22E-03
Wiskott-Aldrich syndrome-like WASL Ssc.21951 1.14 2.61E-04 3.63E-05
epidermal growth factor receptor EGFR Ssc.55 1.73 8.08E-05 7.99E-06
V-Yes-1 Yamaguchi sarcoma viral oncogene YES1 Ssc.6801 1.27 1.78E-02 7.72E-03
WAS protein family member 3 WASF3 Ssc.4177 1.29 2.87E-03 7.68E-04
Partitioning defective 3 homolog PARD3 Ssc.1382 1.57 4.38E-04 6.93E-05
fibroblast growth factor receptor 1 FGFR1 Ssc.17773 1.41 1.95E-01 2.00E-01
transcription factor 7-like 2 TCF7L2 Ssc.19409 1.41 9.77E-05 1.03E-05
Cell adhesion molecules activated leukocyte cell adhesion molecule ALCAM Ssc.13385 1.61 2.21E-03 5.47E-04
CD276 antigen CD276 Ssc.2042 1.51 2.10E-04 2.74E-05
CD34 antigen CD34 Ssc.15747 1.20 2.02E-02 9.04E-03
CD99 antigen CD99 Ssc.3205 1.29 8.12E-04 1.54E-04
claudin 3 CLDN3 Ssc.9102 1.53 3.22E-02 1.65E-02
claudin 5 CLDN5 Ssc.4227 2.04 3.36E-04 4.98E-05
huel-interacting protein ESAM Ssc.23336 1.44 4.48E-04 7.12E-05
F11 receptor F11R Ssc.29060 1.20 4.37E-04 6.90E-05
major histocompatibility complex, class I, A HLA-A Ssc.13780 1.52 9.76E-03 3.58E-03
major histocompatibility complex, class II, DM alpha HLA-DMA Ssc.13777 1.14 4.03E-02 2.22E-02
intercellular adhesion molecule 1 (CD54) ICAM1 Ssc.11187 1.31 8.54E-03 3.03E-03
integrin, beta 8 ITGB8 Ssc.23798 2.63 2.22E-03 5.53E-04
junctional adhesion molecule 2 JAM2 Ssc.9217 1.49 2.14E-04 2.81E-05
neural cell adhesion molecule 1 NCAM1 Ssc.6092 1.41 1.79E-02 7.76E-03
platelet/endothelial cell adhesion molecule (CD31) PECAM1 Ssc.14558 1.24 1.07E-02 4.01E-03
protein tyrosine phosphatase, receptor type, F PTPRF Ssc.2337 1.26 8.98E-03 3.22E-03
syndecan 2 SDC2 Ssc.2485 1.51 9.36E-07 1.54E-08
selectin E SELE Ssc.16297 2.58 1.72E-02 7.41E-03
Notch signaling presenilin 1 PSEN1 Ssc.12937 1.24 6.03E-04 1.05E-04
numb homolog NUMB Ssc.20190 1.13 3.63E-03 1.03E-03
E1A binding protein EP300 Ssc.22177 1.13 3.24E-02 1.66E-02
CREB binding protein CREBBP Ssc.17277 1.16 4.14E-03 1.22E-03
SNW domain containing 1 SNW1 Ssc.17288 1.21 4.25E-02 2.39E-02
Notch homolog 1, trasnlocation-associated NOTCH1 Ssc.26169 1.32 5.34E-03 1.68E-03
KIAA1528 protein DTX2 Ssc.26800 1.31 3.07E-03 8.38E-04
C-terminal binding protein 2 CTBP2 Ssc.27641 1.95 1.29E-06 2.77E-08
notch homolog 2 NOTCH2 Ssc.19892 1.29 3.99E-04 6.18E-05
mastermind-like 2 MAML2 Ssc.27051 1.37 4.10E-04 6.39E-05
*Fold changes are expressed as (fasted/ad libitum), in which positive fold changes indicate upregulation of expression due to fasting.
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lating migration and morphological differentiation of endothe-
lial cells. Thus, our study indicates that a number of angiogenic
factors, including VEGF, ANG, AGGF1, IL-8, and IGF-II,
were significantly upregulated with fasting in the pig model.
Transcription factors endothelial PAS domain protein 1
(EPAS-1) and forkhead box C2 (FOXC2) have been identified
as transcriptional regulators of angiogenic genes (72, 80). In
response to fasting in pigs in our study, EPAS-1 and FOXC2
were significantly upregulated 1.4 and 1.7-fold, respectively.
EPAS-1 is a basic helix-loop-helix/PAS domain TF that is
expressed most abundantly in highly vascularized organs (79).
EPAS-1 promotes angiogenesis via transactivation of VEGF
and its receptor (72, 79), which agrees with our finding of
fasting induced VEGF expression. FOXC2 was studied in a
transgenic mouse model and increased expression of FOXC2
in adipose tissue promotes angiogenesis and vascular pattern-
ing (33, 80). FOXC2 directly targets integrin beta 3 (ITGB3),
hairy and enhancer of split-related protein 2 (HEY2), and
ANG2 (80) to promote angiogenesis; ITGB3 was upregulated
1.26-fold (q  1.79E-06), while HEY2 had tendency to be
upregulated 1.21-fold (q  0.07) with fasting (Table 2).
Angiopoietin-like peptides (ANGPTL), such as ANGPTL 3,
4, and 6, have been shown to be involved in lipid, glucose, and
energy metabolism independent of angiogenic effects (30). Of
these ANGPTL, the Affymetrix array contained a transcript for
only ANGPTL4, which was 2-fold upregulated in fasted
pigs. Angiopoietin-like 4 has been shown to increase plasma
TG levels via direct inhibition of lipoprotein lipase (51, 69) and
may explain the tendency for increased levels (P  0.07) of
TG in the fasted group. The role of ANGPTL4 in angiogenesis
is not clear and may have both pro- and antiangiogenic effects
(11, 45). Although angiogenesis has been suggested to be an
indicator for adipogenesis (10, 32), our data indicate decreased
lipid biosynthesis (i.e., adipogenesis). Angiogenesis may have
a negative relationship with adipogenesis during fasting-in-
duced responses in growing animals, as the positive relation-
ship between angiogenesis and adipogenesis has been estab-
lished only during fetal fat mass development (10, 32). Taken
together, fasting appears to induce expression of a number of
genes in the pathway leading to angiogenesis.
Fasting Induced Upregulation of Genes Involves Cell-to-Cell
and Cell-to-Matrix Communication in Fat
Successful vascular development depends on efficient cell-
to-cell and cell-to-matrix communication and cytoskeletal re-
organization (64). We found that genes such as cadherin-
associated protein, epidermal growth factor receptor (EGFR),
fibroblast growth factor receptor 1 (FGFR1) in the adherens
junction, notch signaling, cell adhesion, and cytoskeletal orga-
nization pathways were significantly upregulated in fat of
fasted pigs (Fig. 2, Supplementary Table 4B). Fasting induced
expression of genes involved in morphological changes in
adipose tissue, and these changes may have been partially
mediated by ESR1, as many of its target genes were overrep-
resented in these pathways and consisted of genes such as
EGFR, FGFR1, and E1A binding protein. Expression of ESR1
was increased 1.8-fold (Ssc.12290, q  1.18E-05, P  1.09E-04)
in fat in response to fasting. No study has yet reported fasting-
induced increases in ESR1 RNA levels in any tissue, although
several metabolic syndromes, such as type II diabetes and athero-
sclerosis have been linked to polymorphisms of ESR1 (26, 34).
Coupled with our finding, this suggests a potential role of ESR1 in
homeostatic mechanisms that regulate fasting-induced changes of
adipocyte cell-to-cell interactions.
Fasting-induced Lipolysis in Fat
Fat serves as the main TG storage site, which, in the face of
feed deprivation, provides free fatty acids in the circulation as
a source of energy by other tissues and for glycerol to be
converted to glucose in liver. The greater concentration of
circulating NEFA in fasted pigs and the significant decrease in
backfat provide evidence for depletion of TG from the adipose
tissue. While fasting induced depletion of TG, the expression
of genes involved in synthesis of lipids decreased with fasting
in both tissues and was verified by qPCR (Fig. 1).
Fasting-induced lipolysis in pigs differs from that in humans
and in rodents and is not associated with increases in glucagon
(66), epinephrine, or norepinphrine (56). Increased sensitivity
of adipose tissue to -adrenergic agonists during fasting in pigs
has been noted (66), and our results suggest that the mecha-
nism behind this may involve RNA level changes, as we found
fasting to induce upregulation of the -adrenergic receptor
gene (Table 3). However, the expression of hormone-sensitive
lipase (HSL) was not altered due to fasting (Table 3). This
result may be species specific, as transcription of HSL was
upregulated in adipose tissue after a 3-day fast in rats (71).
Fasting-induced lipolysis in pigs may therefore be mediated via
a previously described HSL-independent pathway (24). Para-
doxically, TF FOXC2, which is known to increase sensitivity
to cAMP/PKA-dependent signals and induce HSL expression
(12), was increased 1.7-fold due to fasting (Table 3). Thus, the
role of FOXC2 in mediating lipolysis may extend beyond
regulation of HSL expression.
Liver Upregulated Gluconeogenesis and Fatty Acid Oxidation
The main goal of the fasting response is to maintain suffi-
cient glucose concentration in the bloodstream, primarily
through the liver, such that the nervous system has enough fuel.
As with a previous fasting study in pigs (67), glucose concen-
tration in the serum after 3 days of fasting was maintained at a
similar concentration as that of ad libitum-fed pigs. This
glucose homeostasis was likely mediated via gluconeogenesis
and glycolysis pathways, because the genes encoding enzymes
involved in these pathways, such as pyruvate carboxylase (PC),
cytosolic and mitochondrial phosphoenolcarboxykinase 2, and
the rate-limiting enzyme fructose-1,6-bisphosphatase (FBP1),
were upregulated with fasting (Table 3). Although PC has not
been implicated to be the rate-limiting step of hepatic glucone-
ogenesis (52), its 3.7-fold induction by fasting was higher than
that of FBP1 (Table 3) and this was confirmed by qPCR (Fig.
1B). In addition, increased expression of genes involved in oxi-
dation of fatty acids such as acyl-CoA dehydrogenase, enoyl CoA
hydratase 1, and hydroxyacyl-CoA dehydrogenase, was observed
in liver (Table 3) and these were confirmed by qPCR (Fig. 1B).
The energy derived from fatty acid oxidation likely provided fuel
for gluconeogenesis during fast. Furthermore, upregulation of
branched amino acid degradation pathway genes in the liver
suggests the accumulation of gluconeogenic and ketogenic pre-
cursors, utilizing amino acids derived from degradation of pro-
teins by the proteasomal pathway. As adipose tissue does not
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serve as the primary site of glucose sparing during fasting, these
pathways were downregulated in fat.
A key transcriptional regulator of fatty acid oxidation,
PPAR, has previously been implicated in the fasting adapta-
tion of liver in pigs (14). Congruent with fasting-induced
activation of fatty acid oxidation in the liver, PPAR was
upregulated 1.4-fold in our fasted animals. Also, degradation
of amino acids and pyruvate for gluconeogenesis was evi-
denced by upregulation of genes encoding enzymes in the TCA
cycle, such as succinate dehydrogenase complex subunits B
and D and isocitrate dehydrogenases 1 and 3. During fasting in
pigs, the TCA cycle is likely facilitated by acetyl CoA derived
mainly from amino acids and glycerol precursors, rather than
from glucose, because the expression of genes encoding the
pyruvate dehydrogenase complex components, such as E2
component, - and -subunits, and pyruvate dehydrogenase
kinase-4, was not altered (Table 3).
Fasting Effects on Ketogenesis and Hepatic Cell Cycling
With feed deprivation, the increased demand for -oxidation
of fatty acids in the liver results in ketogenesis. However, in
Table 3. The statistical differential expression values of genes and pathways referred to in RESULTS
Pathways Gene Description GenBank Symbol Affymetrix ID Tissue *Fold Change q Value P Value
Gluconeogenesis fructose-1,6-bisphosphatase FBP1 Ssc.5127 liver 1.30 3.35E-04 3.96E-06
phosphoenolcarboxykinase 2 PCK2 Ssc.19382 liver 1.44 8.70E-03 4.30E-04
pyruvate carboxylase PC Ssc.17347 liver 3.73 2.56E-10 6.49E-14
Lipolysis -adenergic receptor gene ADRB1 Ssc.16075 fat 1.30 4.00E-02 2.00E-03
hormone sensitive lipase HSL Ssc.6784 fat 1.05 3.00E-01 4.30E-01
forkhead box C2 FOXC2 Ssc.19569 fat 1.70 2.50E-02 1.20E-02
Adipogenesis peroxisome proliferator-activated receptor gamma PPAR Ssc.15274 fat 1.32 2.39E-04 6.00E-03
CCAAT/enhancer binding protein, alpha C/EBP Ssc.15991 fat 1.44 9.60E-03 3.50E-03
sterol regulatory element binding factor 1 SREBF1 Ssc.15992 fat 2.57 4.75E-04 7.69E-05
Fatty acid oxidation acyl-CoA dehydrogenase, long chain ACADL Ssc.14530 liver 2.34 9.43E-07 2.79E-09
enoyl CoA hydratase 1 ECH1 Ssc.5099 liver 2.27 2.83E-07 5.39E-10
hydroxyacyl-CoA dehydrogenase HADHA Ssc.11580 liver 2.43 1.08E-06 3.31E-09
acetyl CoA acyltransferase ACAA1 Ssc.1225 liver 1.50 1.73E-05 9.59E-08
carnitine palmitoyltransferase 1A CPT1A Ssc.8974 liver 1.64 7.70E-03 3.63E-04
peroxisome proliferator-activated receptor alpha PPAR Ssc.9348 liver 1.40 5.80E-03 2.28E-04
Glucose metabolism E2 component of pyruvate dehydrogenases PDCE2 Ssc.14134 liver 1.10 1.80E-01 5.10E-02
-subunit of pyruvate dehydrogenase PDHA1 Ssc.16248 liver 1.00 6.60E-01 9.60E-01
-subunit of pyruvate dehydrogenase PDHB Ssc.7604 liver 1.03 5.00E-01 4.50E-01
pyruvate dehydrogenase kinase-4 PDK4 Ssc.1121 liver 1.04 5.90E-01 6.70E-01
Ketogenesis 3-hydroxymethyl-3-methylglutaryl-CoA lyase HMGCL Ssc.27317 liver 1.30 1.50E-02 9.80E-04
3-hydroxymethylglutaryl-CoA synthase 1 HMGCS1 Ssc.11126 liver 7.33 1.02E-08 1.12E-11
acetyl CoA acetyltransferase 2 ACAT2 Ssc.4426 liver 9.10 1.94E-07 3.10E-10
Biosynthesis of steroid 3-hydroxy-3-methylglutaryl-coenzyme A reductase HMGCR Ssc.16088 fat 1.54 8.10E-03 2.84E-03
7-dehydrocholesterol reductase DHCR7 Ssc.5455 fat 3.45 3.50E-04 5.30E-05
sterol isomerase EBP Ssc.5045 fat 4.04 5.29E-06 1.99E-07
isopentenyl-diphosphate delta isomerase 1 IDI1 Ssc.6714 fat 5.60 1.01E-06 1.77E-08
sterol-C5-desaturase SC5DL Ssc.15727 fat 3.57 2.70E-07 2.12E-09
mevalonate kinase MVK Ssc.3345 fat 4.95 2.25E-04 3.01E-05
mevalonate decarboxylase MVD Ssc.4685 fat 6.50 4.43E-05 3.62E-06
squalene epoxidase SQLE Ssc.8385 fat 1.44 3.07E-02 1.55E-02
geranyl geranyl diphosphate synthase GGPS1 Ssc.14178 fat 1.22 1.78E-03 4.15E-04
farnesyl diphosphate farnesyltransferase 1 FDFT1 Ssc.6418 fat 1.09 1.61E-01 1.50E-01
sterol regulatory element binding factor 2 SREBF2 Ssc.16976 fat 1.23 3.40E-02 1.80E-02
3-hydroxy-3-methylglutaryl-coenzyme A reductase HMGCR Ssc.16088 liver 6.70 3.74E-07 7.88E-10
7-dehydrocholesterol reductase DHCR7 Ssc.5455 liver 5.72 1.24E-08 1.45E-11
sterol isomerase EBP Ssc.5045 liver 3.69 2.56E-10 9.46E-14
isopentenyl-diphosphate delta isomerase 1 IDI1 Ssc.6714 liver 9.94 2.56E-10 3.20E-14
sterol-C5-desaturase SC5DL Ssc.15727 liver 3.36 4.26E-09 3.67E-12
mevalonate kinase MVK Ssc.3345 liver 1.74 9.89E-03 5.21E-04
mevalonate decarboxylase MVD Ssc.4685 liver 4.35 3.49E-04 4.17E-06
squalene epoxidase SQLE Ssc.8385 liver 7.61 1.02E-08 1.14E-11
farnesyl diphosphate farnesyltransferase 1 FDFT1 Ssc.6418 liver 1.71 8.28E-05 6.63E-07
geranyl geranyl diphosphate synthase GGPS1 Ssc.14178 liver 1.11 4.14E-01 2.94E-01
sterol regulatory element binding factor 2 SREBF2 Ssc.15889 liver 2.70 3.70E-02 3.50E-03
Cell cycle regulation E2F transcription factor 1 E2F1 Ssc.1859 liver 1.95 4.17E-03 1.43E-04
CCAAT/enhancer binding protein, delta C/EBP Ssc.10025 liver 1.47 1.55E-02 1.01E-03
tumor protein p53 TP53 Ssc.15917 liver 1.31 4.13E-02 4.29E-03
cyclin-dependent kinase 2 CDK2 Ssc.27616 liver 1.24 4.60E-02 5.00E-03
cyclin E1 CCNE1 Ssc.18187 liver 1.43 4.00E-02 4.00E-03
E2F transcription factor 1 E2F1 Ssc.1859 fat 2.09 1.18E-05 5.90E-07
cyclin-dependent kinase 2 CDK2 Ssc.27616 fat 1.27 1.89E-03 4.50E-04
cyclin E1 CCNE1 Ssc.18187 fat 1.34 6.01E-03 1.96E-03
*Fold changes are expressed as (fasted/ad libitum), in which negative fold changes indicate downregulation, while positive fold changes indicate upregulation
of expression due to fasting.
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our study, genes encoding enzymes involved in ketogenesis,
such as acetyl CoA actyltransferase 2 and 3-hydroxymethyl-
glutaryl-CoA synthase 1 (HMGCS1), were downregulated (Ta-
ble 3), and the expression was verified for HMGCS1 by qPCR
(Fig. 1B). In addition, the serum concentrations of 3-hydroxy-
butyrate (P  0.40) and acetate (P  0.26) were not signifi-
cantly altered after fasting (data not shown). Depletion of only
about 67% of liver glycogen content was observed in our fasted
pigs (Table 1), compared with rodents that show complete liver
glycogen depletion after 3-day fasting. This partly explains the
lack of evidence for ketogenesis because glucose derived from
glycogenolysis and gluconeogenesis during the 3-day fast may
have been sufficient to fuel the nervous system. Differences
between rats and pigs in ketone body generation in response to
feed deprivation have been reported previously (1), and have
been attributed to the low rate of -oxidation in pigs compared
with rodents.
During fasting, rat hepatocytes undergo decreased cell pro-
liferation (43), which is consistent with our finding that liver
genes involved in cell cycling were significantly downregu-
lated. Common regulators of downregulated liver genes due to
fasting included tumor protein 53, E2F1, and C/EBP, and
their target genes were involved in cell cycle or cell prolifer-
ation, such as cyclin-dependent kinase 2 and cyclin E1. This
indicates that a decrease in proliferation of the hepatocytes to
preserve energy during fasting likely occurred in pigs, as
previously seen in rats.
Fasting Downregulated Steroid Biosynthesis in Both Liver
and Fat
In rats, hepatic biosynthesis of steroids was decreased 10-
fold after 48-h fasting (19), and expression of genes encoding
enzymes involved in the steroid biosynthesis pathway was also
significantly downregulated (55). In pigs, a tissue-level de-
crease in cholesterol due to fasting, combined with an in-
creased serum cholesterol concentration, has been reported
(22). Our finding of downregulation of 12 genes encoding
enzymes involved in steroid biosynthesis, in part, explains
these results. The protein SREBF2, which stimulates transcrip-
tion of genes that encode enzymes involved in cholesterol
synthesis (20), was downregulated 2.7-fold in liver and 1.23-
fold in fat in response to fasting in our study (Table 3).
SREBF2 was also one of the 10 TF with the greatest connec-
tivity to the downregulated liver genes and the 18th most
connected among TF of downregulated fat genes, emphasizing
the importance of SREBF2 and steroid synthesis in the adap-
tive response to fasting.
Conclusions
A series of genes and biological pathways that respond to
fasting in pigs was identified. A fasting-induced switch to a
conservation mode of energy utilization by downregulating
costly lipid, steroid, and protein biosynthetic processes was
established. Fasting upregulated genes involved in angiogene-
sis and cell-to-cell signaling in fat and upregulated pathways
involved with efficient energy utilization and conservation in
liver, such as gluconeogenesis and -oxidation of fatty acids.
Our study implicates involvement of several known and sev-
eral new TF in the adaptive fasting response in pigs, including
PPAR, C/EBP, SREBF1, and EPAS-1, FOXC2, and ESR1.
Our results support that during the early fasting stage, lipid
stores are predominantly utilized and fat undergoes morpho-
logical changes that promote angiogenesis. Enhanced angio-
genesis likely provides efficient lipid mobilization into the
bloodstream and such morphological changes that target cell-
to-cell and cell-to-matrix interactions are, in part, transcription-
ally controlled by ESR1.
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